PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 118 filers reported holding PTC THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $545,000 | -93.6% | 55,350 | -93.0% | 0.01% | -93.6% |
Q4 2016 | $8,575,000 | -47.9% | 785,975 | -33.1% | 0.11% | -44.4% |
Q3 2016 | $16,458,000 | -16.3% | 1,174,730 | -58.1% | 0.20% | +63.6% |
Q2 2016 | $19,666,000 | +105.2% | 2,801,286 | +88.3% | 0.12% | -4.7% |
Q1 2016 | $9,583,000 | -69.6% | 1,487,998 | +53.1% | 0.13% | -70.3% |
Q4 2015 | $31,486,000 | +56.0% | 971,793 | +28.6% | 0.43% | +58.1% |
Q3 2015 | $20,178,000 | -27.4% | 755,728 | +30.9% | 0.27% | -17.4% |
Q2 2015 | $27,789,000 | -20.1% | 577,378 | +1.0% | 0.33% | -20.0% |
Q1 2015 | $34,771,000 | +11.3% | 571,423 | -5.3% | 0.41% | +21.7% |
Q4 2014 | $31,233,000 | +24.2% | 603,308 | +5.6% | 0.34% | +20.4% |
Q3 2014 | $25,143,000 | +253.9% | 571,300 | +110.2% | 0.28% | +304.3% |
Q2 2014 | $7,105,000 | +264.9% | 271,813 | +264.8% | 0.07% | +165.4% |
Q1 2014 | $1,947,000 | +76.4% | 74,500 | +14.5% | 0.03% | +73.3% |
Q4 2013 | $1,104,000 | +5.3% | 65,050 | +33.2% | 0.02% | +15.4% |
Q3 2013 | $1,048,000 | – | 48,850 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |